Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, Hao Chen, Hilaire C. Playa, Shanshan Deng, Deanna N. Parke, John Abernathy, Leona Middleton, Alexandra Cullom, Bhargavi Thalluri, Dejian Ma, Bernd Meibohm, Duane D. Miller, Tiffany Nicole Seagroves, Wěi Li
This study evaluates the biological activity of 60c, a next-generation colchicine-binding site inhibitor, showing improved potency and anti-metastatic effects in triple-negative breast cancer models.
Cancer Letters · May 23, 2024Peer-reviewedCancer Biology